As a member of the firm’s M&A group, Ro guides his clients through high-stakes public and private mergers and acquisitions, venture capital financings and securities offerings representing an aggregate value of more than $221 billion. He focuses on cutting-edge technology and biotechnology transactions and is one of the go-to M&A advisers for complex cross-border transactions in these fields. Ro also regularly advises boards of directors and special committees on activist defense, proxy contests and corporate governance matters.

Download full bio 

Experience

  • Meredith Agrees to Sell National Media Group to IAC’s Dotdash 

  • Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion 

  • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 

  • Prothena Agrees to Sell ATTR Amyloidosis Program to Novo Nordisk 

  • VelosBio Agrees to Sell to Merck for $2.75 Billion 

  • View all

Education

  • University of Pennsylvania Law School; Wharton School, University of Pennsylvania
    LLM; Wharton Business and Law Certificate

  • Seoul National University College of Law
    LLB


Admissions & Credentials

California

New York